Wells Fargo’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
Other funds holding FENC
ACM
AIC
PCA
Wells Fargo's FENC Position: Q3 2026 in Review
Wells Fargo reduced its Fennec Pharmaceuticals (FENC) stake by 66% in Q3 2026, selling an estimated $194K and leaving 8,899 shares worth $94.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5162.
Wells Fargo first reported a position in FENC in Q2 2018 and has held it in 27 quarters since. The position peaked at $1.16M in Q1 2021. 119 funds tracked by Wall St. Rank hold FENC as of Q3 2026.
- Wells Fargo held 8,899 shares of Fennec Pharmaceuticals worth $94.8K as of Q3 2026.
- Wells Fargo sold 17,665 Fennec Pharmaceuticals shares in Q3 2026, an estimated $194K.
- Fennec Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #5162 holding.
- Wells Fargo first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 27 quarters since.
- Wells Fargo's Fennec Pharmaceuticals position peaked at $1.16M in Q1 2021.
- 119 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.